BC
Birchview Capital Portfolio holdings
AUM
$101M
1-Year Return
34.62%
This Quarter Return
-29.4%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$106M
AUM Growth
-$49.2M
(-32%)
Cap. Flow
+$3.45M
Cap. Flow
% of AUM
3.27%
Top 10 Holdings %
Top 10 Hldgs %
82.96%
Holding
60
New
6
Increased
11
Reduced
8
Closed
8
Top Buys
| 1 |
EQM
EQM Midstream Partners, LP
EQM
|
$2.16M |
| 2 |
CELG
Celgene Corp
CELG
|
$1.85M |
| 3 |
CMTA
Clementia Pharmaceuticals Inc.
CMTA
|
$1.18M |
| 4 |
QuidelOrtho
QDEL
|
$639K |
| 5 |
ARRY
Array Biopharma Inc
ARRY
|
$570K |
Top Sells
| 1 |
EQT Corp
EQT
|
$871K |
| 2 |
CFRX
ContraFect Corporation
CFRX
|
$854K |
| 3 |
Ovintiv
OVV
|
$422K |
| 4 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
$397K |
| 5 |
Axogen
AXGN
|
$369K |
Sector Composition
| 1 | Healthcare | 95.72% |
| 2 | Energy | 3.02% |
| 3 | Materials | 0.13% |
| 4 | Industrials | 0.12% |
| 5 | Consumer Staples | 0.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
TG Therapeutics
TGTX
$4.95B
| $62K | 0.06% |
15,000
| – | – |
|
52
Workhorse Group
WKHS
$19.4M
| $13K | 0.01% |
100
| – | – |
|
|
53
Axogen
AXGN
$706M
| – | – |
-10,000
| Closed | -$369K |
|
54
Opko Health
OPK
$1.1B
| – | – |
-103,956
| Closed | -$360K |
|
55
Solid Biosciences
SLDB
$428M
| – | – |
-400
| Closed | -$283K |
|
|
BIOL
56
DELISTED
Biolase, Inc.
BIOL
| – | – |
-16
| Closed | -$83K |
|
|
AVEO
57
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| – | – |
-12,000
| Closed | -$397K |
|
|
TSRO
58
DELISTED
TESARO, Inc.
TSRO
| – | – |
-8,200
| Closed | -$320K |
|
|
ECYT
59
DELISTED
Endocyte, Inc. Common Stock
ECYT
| – | – |
-14,000
| Closed | -$249K |
|
|
GNCA
60
DELISTED
Genocea Biosciences, Inc.
GNCA
| – | – |
-23,625
| Closed | -$147K |
|